NCT01642485
- Conditions
- Behavior, C-Peptide Effects on the QT/QTc Interval, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
- Locations
-
- Richmond Pharmacology Ltd London, Tooting, United Kingdom
Clinical trial condition
Insulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic Use
Explore clinical trials studying Insulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic Use. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies